Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.32
-0.08 (-1.48%)
Apr 29, 2026, 4:08 PM HKT

Lepu Biopharma Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Market Capitalization
9,6008,9684,4826,98612,197-
Upgrade
Market Cap Growth
41.00%100.10%-35.85%-42.72%--
Upgrade
Enterprise Value
9,6899,3484,6717,19611,782-
Upgrade
Last Close Price
5.324.972.624.217.35-
Upgrade
PE Ratio
32.1030.83----
Upgrade
PS Ratio
9.238.6211.4528.14692.84-
Upgrade
PB Ratio
6.335.916.187.1411.98-
Upgrade
P/TBV Ratio
9.749.1015.7413.7123.98-
Upgrade
EV/Sales Ratio
9.318.9911.9328.99669.30-
Upgrade
EV/EBITDA Ratio
77.7677.65----
Upgrade
EV/EBIT Ratio
-322.79----
Upgrade
Debt / Equity Ratio
0.780.781.250.840.770.40
Upgrade
Debt / EBITDA Ratio
9.789.78----
Upgrade
Net Debt / Equity Ratio
0.070.070.550.280.010.14
Upgrade
Net Debt / EBITDA Ratio
0.920.92-1.19-0.81-0.02-0.14
Upgrade
Net Debt / FCF Ratio
---1.63-0.89-0.02-0.14
Upgrade
Asset Turnover
0.350.350.160.090.01-
Upgrade
Inventory Turnover
2.402.402.871.060.08-
Upgrade
Quick Ratio
0.940.940.540.620.830.39
Upgrade
Current Ratio
0.980.980.620.750.960.57
Upgrade
Return on Equity (ROE)
25.32%25.32%-54.02%-3.39%-80.03%-87.61%
Upgrade
Return on Assets (ROA)
0.60%0.60%-10.61%-9.94%-17.41%-26.18%
Upgrade
Return on Invested Capital (ROIC)
1.77%2.05%-36.10%-38.10%-68.31%-98.74%
Upgrade
Return on Capital Employed (ROCE)
1.30%1.30%-32.00%-26.30%-38.10%-61.60%
Upgrade
Earnings Yield
3.03%3.24%-9.77%-0.35%-6.39%-
Upgrade
FCF Yield
-0.67%--5.45%-4.40%-5.48%-
Upgrade
Buyback Yield / Dilution
-3.82%-3.82%-1.87%-1.14%-7.92%-33.97%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.